Stockreport

Actuate to Participate in Lantern’s Pharma Webinar on AI-Driven Drug Development

Actuate Therapeutics, Inc. - Common stock  (ACTU) 
PDF Companies will discuss how Lantern’s AI platform is being leveraged for the identification and development of enrichment biomarkers for Actuate’s lead investigational dr [Read more]